Member Info for Retireby40

Agreed. Given Covid reared its head again I expect the Covid LFT sales will continue to do well and especially the 7 week period in question and so far this year too.

Bella FY22 will include around 7 weeks of Launch’s revenue. That said I expect we will start to regain momentum like last year. Hopefully beyond 52 week high.

I assume the Thursday RNS thing a joke as a quick look back says Thursday is as likely as a Monday or Tuesday for example. Around 20% of RNSs land on a Thursday.

www.google.com and type AACR 23

Money hard to come by but wow you keep posting and are only some £200 down. Get a grip. You shouldn’t be investing in AIM PLCs if you’re this anxious.

Not sure re Bronte but Jupiter has gone from around 1.25m short, reduced to nothing and is now shy of 1m long.

It seems clear to me that they are waiting for regulatory sign off in the new trial design which is why they didn’t state what the next 2 DEs will be. Once they have approval they will communicate it and start dosing.

News on next DEs imminent. How much beyond 240 do they go for DE4?

So Bronte reducing and Jupiter went from 1.25m short to nearly 800k long. A nice turn around. Also let’s not forget we have had 2 conversions in 3 weeks when we were expecting 2 every 6 months.

Likely waiting for regulatory sign off

Gj WTF -

Selling some of your pot at the top with a view to buying back in lower can also be considered a form of shorting.

The above is called trading!! Unless someone is just selling stock to buy back in order to return said stock and make money it’s not shorting.

Tiger the share price is faltering due to C5 not starting and surely regulators will sign off increased dosed soon.

The platform is doing as intended and news on licensing deals could drop any day.

We are still some 45% above placing snd remember we’ve had 2 in the space of 3 weeks rather than 26 weeks (2 quarters).

He moved back to Boston with Point Biopharma so not a red flag IMO.

Hi Tom,

I tweeted a drunken Elon Musk rant for which I apologised. Can you please unblock me? Keen to see your tweets again, particularly Avacta ones!

https://twitter.com/rah00084/status/1628655140214276099?s=46&t=5wFQ6d5NeH_yqvAfD2Y4bA

So 6000 is P1 and 3996 is pre-clinical.

I think it superb. Meant to be 1 conversion every 3 months and we’ve got 2 away in 3 weeks. Share price still okay and believers can increase before data published if they want. Looks good to me. I can’t see Tap flying over to talk generically and regurgitate the 17 Jan RNS so I expect hard data to reinforce the potential risk. Not long to find out.

Good for them. We were due to have one conversion every 3 months yet we’ve had 2 in 3 weeks so over 10% of loan paid off and over 65% above raise price. Bodes well.s

Plenty of sells above mid (which is good to see).

170.09259 135,000 £229.62k. Nice buy just after close.